BrownForman (BF.B)
(Delayed Data from NYSE)
$43.59 USD
-0.44 (-1.00%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $44.00 +0.41 (0.94%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$43.59 USD
-0.44 (-1.00%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $44.00 +0.41 (0.94%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
Zacks News
Outlook for Alcohol Industry Dim on Soft Beer Sales & Tariffs
by Zacks Equity Research
Beer brands are struggling due to industry-wide softening of volumes. But, the industry can revive on product innovation, premiumization, use of natural ingredients and cannabis-infused drinks.
Brown-Forman Corporation (BF.B) Up 6.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Brown-Forman Corporation (BF.B) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Balanced Risk-Reward for Brown-Forman (BF.B): Stock Gains
by Zacks Equity Research
Brown-Forman (BF.B) witnesses strength across its brand portfolio and geographies, which is aiding bottom-line performance. But ongoing tariff-related and higher input costs are headwinds.
Johnson and Johnson Opioid Lawsuit and More Doom and Gloom
by Panel Of Zacks Experts
The market bounces back while Erique and Danny talk about Whiskey, Johnson and Johnson and continued trade war. The portfolios stay put while showing a lot of green, see what happens on this episode of Paper Traders.
Trade Concerns Continue to Weigh on Markets
by Zacks Equity Research
Trade Concerns Continue to Weigh on Markets
Trade War Hits New Earnings Reports: BF.B, TIF & More
by Mark Vickery
The good news is that both Brown-Forman and Tiffany & Co. beat on their respective bottom lines, though neither managed to reach revenue estimates for the quarter.
Brown-Forman (BF.B) Q1 Earnings Beat, Tariffs Hurt Sales
by Zacks Equity Research
Brown-Forman's (BF.B) first-quarter fiscal 2020 results reflect impacts of tariffs and timing of customer orders despite strength in the United States.
Brown-Forman Corporation (BF.B) Q1 Earnings Beat Estimates
by Zacks Equity Research
Brown-Forman Corporation (BF.B) delivered earnings and revenue surprises of 5.41% and -0.80%, respectively, for the quarter ended July 2019. Do the numbers hold clues to what lies ahead for the stock?
Boston Beer (SAM) Up 44% in 6 Months: Will Momentum Sustain?
by Zacks Equity Research
Boston Beer (SAM) remains committed to the three-point growth plan. Also, the company's focus on cost savings, long-term innovation, and the revival of Samuel Adams and Angry Orchard brands bode well.
Analysts Estimate Brown-Forman Corporation (BF.B) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Brown-Forman Corporation (BF.B) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Brown-Forman (BF.B) Beat on Q1 Earnings Amid Tariff Woes?
by Zacks Equity Research
Brown-Forman's (BF.B) first-quarter fiscal 2020 will reflect gains from strength in its brand portfolio, product innovation and expansion. But higher tariff and other input costs may hinder results.
Keurig Dr Pepper (KDP) Q2 Earnings Beat, Sales Lag Estimates
by Zacks Equity Research
Keurig Dr Pepper (KDP) posts mixed results in second-quarter 2019. Nevertheless, management reaffirms guidance for the current year.
Can Brown-Forman (BF.B) Withstand Tariff-Related Perils?
by Zacks Equity Research
Brown-Forman (BF.B) is in rough waters, thanks to impacts of higher tariffs imposed on American spirits. However, its strong brand portfolio and innovation efforts may help it sail through.
Top Stock Reports for Berkshire Hathaway, salesforce & Danaher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), salesforce (CRM) and Danaher (DHR).
Aluminum Tariff Lift & More Factors to Keep Aiding AB InBev
by Zacks Equity Research
AB InBev (BUD) keeps the momentum alive on robust sales trend, growth of global brands and strong forward outlook. Additionally, the recent lifting of aluminum tariffs is likely to aid performance.
Brown-Forman's (BF.B) Fords Gin Buyout to Enhance Portfolio
by Zacks Equity Research
Brown-Forman (BF.B) agrees to buy The 86 Company, bringing the Fords Gin trademark to its growing portfolio of premium gins. This should fortify its strong spirits portfolio.
Brown-Forman (BF.B) Tops Q4 Earnings Estimates, Sales Lag
by Zacks Equity Research
Brown-Forman's (BF.B) earnings beat estimates in fourth-quarter fiscal 2019, while sales missed estimates. The company provides robust view for fiscal 2020.
Brown-Forman Corporation (BF.B) Beats Q4 Earnings Estimates
by Zacks Equity Research
Brown-Forman Corporation (BF.B) delivered earnings and revenue surprises of 13.79% and -2.33%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?
Brown-Forman Corporation (BF.B) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Brown-Forman Corporation (BF.B) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors Likely to Influence Brown-Forman's (BF.B) Q4 Earnings
by Zacks Equity Research
Brown-Forman's (BF.B) Q4 results are likely to benefit from robust brand portfolio. However, tariff-related costs are hurting underlying net sales and gross margin.
Beverages - Alcohol Industry Trends Suggest Growth in the Future
by Rajani Lohia
The alcohol space looks poised for growth as premium and innovative beverages are gaining traction. Meanwhile, cannabis drinks provide a lucrative opportunity for growth.
Brown-Forman Corporation (BF.B) Up 6.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Brown-Forman Corporation (BF.B) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Microsoft, Mastercard, General Electric, Target and Brown-Forman
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, Mastercard, General Electric, Target and Brown-Forman
Brown-Forman Corporation (BF.B) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Brown-Forman Corporation (BF.B) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Top Research Reports for Microsoft, Mastercard & General Electric
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Mastercard (MA) and General Electric (GE).